Innate Pharma S.A. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
IPHA Nasdaq 2836 www.innate-pharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Innate Pharma S.A.

Outcome of Innate Pharma’s 2026 Annual General Meeting - May 21st, 2026 11:00 pm
Innate Pharma to participate in the Jefferies Global Healthcare Conference - May 18th, 2026 11:00 pm
Innate Pharma Q1 Earnings Call Highlights - May 13th, 2026 10:07 am
Innate Pharma Reports First Quarter 2026 Business Update and Financial Results - May 12th, 2026 11:00 pm
Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026 - May 11th, 2026 11:00 pm
Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update - May 5th, 2026 11:00 pm
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight - Apr 27th, 2026 11:00 am
Innate Pharma to Participate in the D. Boral Capital Global Conference - Apr 22nd, 2026 11:00 pm
Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026 - Apr 17th, 2026 1:00 pm
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Apr 12th, 2026 11:00 pm
Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026 - Apr 12th, 2026 11:00 pm
Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event - Apr 7th, 2026 11:00 pm
Innate Pharma to Participate in the Kempen Life Sciences Conference - Apr 2nd, 2026 11:00 pm
Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) and 2025 Form 20-f Annual Report - Apr 2nd, 2026 2:00 am
How Innate Pharma (ENXTPA:IPH) Story Is Shifting Around 2026 Catalysts And €8 Target - Mar 27th, 2026 12:06 am
Innate Pharma SA (IPHA) Full Year 2025 Earnings Call Highlights: Strategic Advances and ... - Mar 26th, 2026 1:00 pm
Innate Pharma Q4 Earnings Call Highlights - Mar 26th, 2026 9:08 am
Innate Pharma Reports Full Year 2025 Financial Results and Business Update - Mar 26th, 2026 12:00 am
Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results - Mar 19th, 2026 12:00 am
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026 - Feb 18th, 2026 11:00 pm